• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用钆塞酸增强 MRI 鉴别混合细胞型肝癌和巨块型肝内胆管细胞癌。

Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI.

机构信息

Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

出版信息

J Magn Reson Imaging. 2012 Oct;36(4):881-9. doi: 10.1002/jmri.23728. Epub 2012 Jun 21.

DOI:10.1002/jmri.23728
PMID:22730271
Abstract

PURPOSE

To examine the differential features of combined hepatocellular and cholangiocarcinoma (HCC-CC) from mass-forming intrahepatic cholangiocarcinoma (ICC) on gadoxetic acid-enhanced MRI.

MATERIALS AND METHODS

Forty patients with pathologically proven combined HCC-CC (n = 20) and ICCs (n = 20) who had undergone gadoxetic acid-enhanced MRI were enrolled in this study. MR images were analyzed for the shape of lesions, hypo- or hyperintense areas on the T2-weighted image (T2WI), rim enhancement during early dynamic phases, and central enhancement with hypointense rim (target appearance) on the 10-min and 20-min hepatobiliary phase (HBP). The significance of these findings was determined by the χ(2) test.

RESULTS

Irregular shape and strong rim enhancement during early dynamic phases, and absence of target appearance on HBP favored combined HCC-CCs (P < 0.05). Lobulated shape, weak peripheral rim enhancement, and the presence of complete target appearance on the 10-min and 20-min HBP favored ICCs (P < 0.05). However, 10 CC-predominant type of combined HCC-CC showed complete or partial target appearance on 10-min HBP.

CONCLUSION

The shape of tumors, degree of rim enhancement during early dynamic phases, and target appearance on HBP were valuable for differentiating between combined HCC-CC and mass-forming ICC on gadoxetic acid-enhanced MRI.

摘要

目的

探讨钆塞酸增强 MRI 鉴别富血供型肝内胆管细胞癌(ICC)与胆管细胞癌-肝细胞癌混合型(HCC-CC)的特征。

材料与方法

回顾性分析经病理证实的 40 例 HCC-CC(20 例)和 ICC(20 例)患者的临床及影像资料。分析病变的形态、T2WI 信号、早期动态增强扫描的边缘强化程度、10 分钟和 20 分钟肝胆期(HBP)是否存在“靶征”。采用 χ(2)检验分析各征象对两种肿瘤的鉴别诊断价值。

结果

不规则形态、早期边缘强化显著、HBP 无“靶征”提示 HCC-CC(P<0.05);分叶状形态、边缘强化轻、10 分钟和 20 分钟 HBP 均存在完整或部分“靶征”提示 ICC(P<0.05)。10 例 HCC 为主型 HCC-CC 中 10 分钟 HBP 可见完全或部分“靶征”。

结论

肿瘤的形态、早期边缘强化程度、HBP 上的“靶征”对鉴别 HCC-CC 与富血供型 ICC 有一定价值。

相似文献

1
Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI.使用钆塞酸增强 MRI 鉴别混合细胞型肝癌和巨块型肝内胆管细胞癌。
J Magn Reson Imaging. 2012 Oct;36(4):881-9. doi: 10.1002/jmri.23728. Epub 2012 Jun 21.
2
Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI.使用钆塞酸增强 MRI 鉴别富血供型肝内胆管细胞癌与不典型肝细胞癌。
Clin Radiol. 2012 Aug;67(8):766-73. doi: 10.1016/j.crad.2012.01.004. Epub 2012 Mar 15.
3
Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma.小肝内肿块型胆管癌:扩散加权成像上的靶征用于与肝细胞癌鉴别
Abdom Imaging. 2013 Aug;38(4):793-801. doi: 10.1007/s00261-012-9943-x.
4
Scirrhous hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging: emphasis on the differentiation of intrahepatic cholangiocarcinoma.钆塞酸增强磁共振成像及扩散加权成像上的硬化型肝细胞癌:着重于肝内胆管癌的鉴别诊断
J Comput Assist Tomogr. 2013 Nov-Dec;37(6):872-81. doi: 10.1097/RCT.0b013e31829d44c1.
5
Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.钆塞酸二钠增强肝脏磁共振成像上肝内肿块型胆管癌与肝细胞癌的鉴别诊断
Eur Radiol. 2016 Jun;26(6):1808-17. doi: 10.1007/s00330-015-4005-8. Epub 2015 Sep 15.
6
Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.肝内肿块型胆管细胞癌:钆塞酸增强磁共振成像的增强模式。
Radiology. 2012 Sep;264(3):751-60. doi: 10.1148/radiol.12112308. Epub 2012 Jul 12.
7
The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma.钆贝葡胺增强肝胆期磁共振成像在鉴别硬化型肝细胞癌与胆管癌(伴或不伴肝细胞癌)中的价值
Abdom Imaging. 2010 Jun;35(3):337-45. doi: 10.1007/s00261-009-9509-8. Epub 2009 Apr 7.
8
Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.钆塞酸二钠增强 MRI 成像对肝内胆管细胞癌的影像学特征。
Eur J Radiol. 2013 Mar;82(3):e101-6. doi: 10.1016/j.ejrad.2012.10.010. Epub 2012 Nov 16.
9
Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.在钆塞酸增强肝胆期 MRI 上见到的肝脏高信号病变的鉴别诊断。
AJR Am J Roentgenol. 2011 Jul;197(1):W44-52. doi: 10.2214/AJR.10.5845.
10
Differentiation between inflammatory myofibroblastic tumor and cholangiocarcinoma manifesting as target appearance on gadoxetic acid-enhanced MRI.在钆塞酸增强 MRI 上表现为靶征的炎性肌纤维母细胞瘤与胆管细胞癌的鉴别诊断。
Abdom Radiol (NY). 2019 Apr;44(4):1395-1406. doi: 10.1007/s00261-018-1847-y.

引用本文的文献

1
Modified LR-5 criteria based on gadoxetic acid can improve the sensitivity in the diagnosis of hepatocellular carcinoma.基于钆塞酸的改良LR-5标准可提高肝细胞癌诊断的敏感性。
World J Radiol. 2025 Mar 28;17(3):103822. doi: 10.4329/wjr.v17.i3.103822.
2
Combined hepatocellular cholangiocarcinoma: A clinicopathological update.肝细胞胆管癌合并症:临床病理进展
World J Hepatol. 2024 May 27;16(5):766-775. doi: 10.4254/wjh.v16.i5.766.
3
Recent Advancement in Diagnosis of Biliary Tract Cancer through Pathological and Molecular Classifications.
通过病理和分子分类在胆道癌诊断方面的最新进展
Cancers (Basel). 2024 May 1;16(9):1761. doi: 10.3390/cancers16091761.
4
Cholangiocarcinoma imaging: from diagnosis to response assessment.胆管癌影像学:从诊断到疗效评估。
Abdom Radiol (NY). 2024 May;49(5):1699-1715. doi: 10.1007/s00261-024-04267-y. Epub 2024 Apr 5.
5
How to differentiate between combined hepatocellular carcinoma-cholangiocarcinoma and intrahepatic cholangiocarcinoma with rim arterial phase hyperenhancement?如何区分具有边缘动脉期增强的肝细胞癌-胆管细胞癌和肝内胆管细胞癌?
Abdom Radiol (NY). 2024 Sep;49(9):3015-3023. doi: 10.1007/s00261-024-04194-y. Epub 2024 Mar 1.
6
A convenient scoring system to distinguish intrahepatic mass-forming cholangiocarcinoma from solitary colorectal liver metastasis based on magnetic resonance imaging features.基于磁共振成像特征的一种用于鉴别肝内肿块型胆管细胞癌与单发结直肠肝转移瘤的简便评分系统。
Eur Radiol. 2023 Dec;33(12):8986-8998. doi: 10.1007/s00330-023-09873-w. Epub 2023 Jul 1.
7
Update on Pathologic and Radiologic Diagnosis of Combined Hepatocellular-Cholangiocarcinoma.肝细胞-胆管细胞癌联合病理与放射学诊断的最新进展
J Liver Cancer. 2021 Mar;21(1):12-24. doi: 10.17998/jlc.21.1.12. Epub 2021 Mar 31.
8
Radiomics Based on Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Preoperative Differentiation of Combined Hepatocellular-Cholangiocarcinoma from Hepatocellular Carcinoma: A Multi-Center Study.基于动态对比增强磁共振成像的放射组学在术前鉴别肝细胞癌合并胆管癌与肝细胞癌中的多中心研究
J Hepatocell Carcinoma. 2023 Jun 2;10:795-806. doi: 10.2147/JHC.S406648. eCollection 2023.
9
A meta-analysis of based radiomics for predicting lymph node metastasis in patients with biliary tract cancers.基于放射组学预测胆道癌患者淋巴结转移的荟萃分析。
Front Surg. 2023 Jan 6;9:1045295. doi: 10.3389/fsurg.2022.1045295. eCollection 2022.
10
Diagnosis of Cholangiocarcinoma.胆管癌的诊断
Diagnostics (Basel). 2023 Jan 8;13(2):233. doi: 10.3390/diagnostics13020233.